7-Keto DHEA for the Treatment of PTSD
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 4/21/2016 |
| Start Date: | February 2013 |
| End Date: | December 2014 |
The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing
symptoms of Post-Traumatic Stress Disorder (PTSD).
symptoms of Post-Traumatic Stress Disorder (PTSD).
The main purpose of the study is to investigate the possible effect of 7-Keto
Dehydroepiandrosterone (7-Keto DHEA) on decreasing Post Traumatic Stress Disorder Symptoms
(PTSD) in a Veteran population. The study proposes, based on a 2006 report, that the use of
the drug will show significant reduction in overall PTSD symptoms, a decrease in
physiological stress response and higher patient-reported quality of life compared to
placebo. This is a Phase 2, randomized, double-blind, crossover design with a placebo
control. The sponsor for this study is Humanetics Corporation
Dehydroepiandrosterone (7-Keto DHEA) on decreasing Post Traumatic Stress Disorder Symptoms
(PTSD) in a Veteran population. The study proposes, based on a 2006 report, that the use of
the drug will show significant reduction in overall PTSD symptoms, a decrease in
physiological stress response and higher patient-reported quality of life compared to
placebo. This is a Phase 2, randomized, double-blind, crossover design with a placebo
control. The sponsor for this study is Humanetics Corporation
Inclusion Criteria:
- Veteran status and enrolled for care in the Veteran Health Administration
- Ages 18-64
- Primary diagnosis of PTSD as assess by the clinician administered PTSD scale and
independent clinical mental health evaluation
Exclusion Criteria:
- psychosis
- Dementia
- Active alcohol and/or substance abuse or dependence
- Active suicidal or homicidal ideation
- Medical concerns that would exclude use of 7-Keto DHEA
We found this trial at
1
site
Click here to add this to my saved trials
